The impact of telemedicine in the care of liver cirrhosis
Închide
Articolul precedent
Articolul urmator
83 1
Ultima descărcare din IBN:
2024-01-10 10:18
SM ISO690:2012
CEBANU, Ecaterina, ŢURCANU, Adela. The impact of telemedicine in the care of liver cirrhosis. In: Perspectives of the Balkan medicine in the post COVID-19 era: The 37th Balkan Medical Week. The 8th congress on urology, dialysis and kidney transplant from the Republic of Moldova “New Horizons in Urology”, Ed. 37, 7-9 iunie 2023, Chişinău. București: Balkan Medical Union, 2023, Ediția 37, p. 146. ISSN Print: ISSN 1584-9244 ISSN-L 1584-9244 Online: ISSN 2558-815X.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Perspectives of the Balkan medicine in the post COVID-19 era
Ediția 37, 2023
Congresul "Perspectives of the Balkan medicine in the post COVID-19 era"
37, Chişinău, Moldova, 7-9 iunie 2023

The impact of telemedicine in the care of liver cirrhosis


Pag. 146-146

Cebanu Ecaterina1, Ţurcanu Adela12
 
1 ”Nicolae Testemițanu” State University of Medicine and Pharmacy,
2 Clinica de Hepatologie si Gastroenterologie HELPA
 
 
Disponibil în IBN: 21 decembrie 2023


Rezumat

Introduction. The development of complications defines the transition from compensated to decompensated liver cirrhosis, a change that is associated with a marked decrease in survival. The integration of telemedicine holds promise in expanding access to health care, promoting liver cirrhosis management, and facilitating monitoring of care visits. Aim of the study. To analyze the bibliographic data regarding the impact of remote surveillance in patients with liver cirrhosis. Methods and material. An advanced search was performed in the PubMed, and Medline databases, taking into account relevant articles, published in the last 5 years. The search English terms used were:” cirrhosis,” remote surveillance,” telemedicine,” telemonitoring”. Results. In relation to other diseases, there is a lack of literature elucidating the impact of telemedicine on liver diseases. Patients with cirrhosis frequently require emergency hospitalizations and may have prolonged hospital stays and frequent readmissions. Many of these hospitalizations could be avoided if patients received more education and access to remote interactions with their medical teams, thereby empowering them to participate in managing their own disease, including changes in sodium intake or medication titration. And not only publications are limited, but gastroenterology specialists also have the lowest level of use of telemedicine methods (7.9%, AGA) in their work with patients. The application of telemonitoring of patients with liver cirrhosis will reduce costs in the health system, increase the overall satisfaction of the patient and increase survival rates as observed in studies with virtual consultations in other fields. Conclusion. Telemedicine may prove to be the guiding force in inter-episode care coordination for patients with cirrhosis. More resources are needed to evaluate telemedicine interventions and to develop the care infrastructure for patients with cirrhosis.